Ceylon Hospitals PLC (COSE:CHL.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Ceylon Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 11,214 | 10,979 | 9,405 | 9,153 | 7,905 | 7,841 | |
Revenue Growth | 12.35% | 16.73% | 2.76% | 15.78% | 0.82% | 41.39% |
Cost of Revenue | 4,656 | 4,546 | 4,252 | 4,014 | 3,095 | 2,880 |
Gross Profit | 6,558 | 6,433 | 5,154 | 5,139 | 4,811 | 4,961 |
Selling, General & Admin | 4,610 | 4,511 | 3,773 | 3,302 | 2,878 | 2,854 |
Other Operating Expenses | 547.94 | 555.25 | 479.37 | 1,254 | 1,020 | 717.5 |
Operating Expenses | 5,158 | 5,066 | 4,253 | 4,556 | 3,898 | 3,571 |
Operating Income | 1,400 | 1,367 | 901.02 | 582.91 | 913.18 | 1,389 |
Interest Expense | -186.86 | -193.05 | -250.67 | -137.83 | -83.35 | -76.56 |
Interest & Investment Income | 37.24 | 37.24 | 51.14 | 99.66 | 207.25 | 81.82 |
Earnings From Equity Investments | - | - | - | - | - | 11.72 |
Currency Exchange Gain (Loss) | 2.33 | 2.33 | 1.51 | - | - | - |
Other Non Operating Income (Expenses) | 4.89 | - | - | -6.84 | -4.54 | -4.01 |
EBT Excluding Unusual Items | 1,258 | 1,213 | 703 | 537.9 | 1,033 | 1,402 |
Gain (Loss) on Sale of Investments | 150.7 | 150.7 | 218.82 | 113.44 | 27.8 | -32.92 |
Gain (Loss) on Sale of Assets | 38.33 | 38.33 | 36.1 | 6.43 | - | 5.2 |
Other Unusual Items | - | - | - | 1.11 | - | 14.45 |
Pretax Income | 1,447 | 1,402 | 957.92 | 658.89 | 1,060 | 1,389 |
Income Tax Expense | 380.72 | 350.39 | 231.91 | 205.07 | 408.65 | 279.38 |
Earnings From Continuing Operations | 1,066 | 1,052 | 726.01 | 453.81 | 651.67 | 1,110 |
Minority Interest in Earnings | -98.75 | -100.66 | -73.41 | -36.62 | -79.84 | -127.2 |
Net Income | 967.52 | 951.15 | 652.6 | 417.19 | 571.83 | 982.32 |
Net Income to Common | 967.52 | 951.15 | 652.6 | 417.19 | 571.83 | 982.32 |
Net Income Growth | 5.79% | 45.75% | 56.43% | -27.04% | -41.79% | 75.31% |
Shares Outstanding (Basic) | 168 | 168 | 168 | 144 | 136 | 135 |
Shares Outstanding (Diluted) | 168 | 168 | 168 | 144 | 136 | 135 |
Shares Change | -3.58% | - | 16.41% | 6.23% | 0.02% | - |
EPS (Basic) | 5.78 | 5.68 | 3.89 | 2.90 | 4.22 | 7.25 |
EPS (Diluted) | 5.78 | 5.68 | 3.89 | 2.90 | 4.22 | 7.25 |
EPS Growth | 9.72% | 45.75% | 34.37% | -31.32% | -41.80% | 75.31% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,198 | 919.56 | 807.25 | -60.01 | -2,110 | 395.27 |
Free Cash Flow Per Share | 7.15 | 5.49 | 4.82 | -0.42 | -15.57 | 2.92 |
Dividend Per Share | 1.100 | 1.100 | 1.000 | 0.500 | 0.575 | 1.250 |
Dividend Growth | 10.00% | 10.00% | 100.00% | -13.04% | -54.00% | 56.25% |
Gross Margin | 58.48% | 58.59% | 54.80% | 56.14% | 60.86% | 63.27% |
Operating Margin | 12.49% | 12.45% | 9.58% | 6.37% | 11.55% | 17.72% |
Profit Margin | 8.63% | 8.66% | 6.94% | 4.56% | 7.23% | 12.53% |
Free Cash Flow Margin | 10.68% | 8.38% | 8.58% | -0.66% | -26.70% | 5.04% |
EBITDA | 2,101 | 2,051 | 1,437 | 1,025 | 1,302 | 1,729 |
EBITDA Margin | 18.74% | 18.68% | 15.27% | 11.20% | 16.48% | 22.05% |
D&A For EBITDA | 700.86 | 683.87 | 535.57 | 442.58 | 389.26 | 339.85 |
EBIT | 1,400 | 1,367 | 901.02 | 582.91 | 913.18 | 1,389 |
EBIT Margin | 12.49% | 12.45% | 9.58% | 6.37% | 11.55% | 17.72% |
Effective Tax Rate | 26.31% | 24.99% | 24.21% | 31.12% | 38.54% | 20.11% |
Advertising Expenses | - | 84.32 | 98.05 | - | - | - |